CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced its 2024 Annual Results.
Shares of Sarepta Therapeutics have struggled for the past year due to concerns about the commercial potential of its gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback